RxDoctor Payments Data

Douglas McLaws, DO

Family Medicine · Manning, IANPI 1922069681

Payments from drug & device makers

$850in general payments, 2019–2025

Across 52 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$252
  • Mylan Specialty L.p.$219
  • Novo Nordisk$162
  • Pfizer$70
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$39
  • Lilly USA, LLC$36
  • plus $72 from 4 others

What the payments were for

  • Food & beverage$83698%
  • Education$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$850 in reported general payments places this provider in the 80th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$9,073
Medicare patients
47
Services billed
137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide31$45,756
EliquisApixaban53$38,226
OzempicSemaglutide29$32,964
Tresiba Flextouch U-200Insulin Degludec26$17,772
Repatha SureclickEvolocumab29$16,054
MounjaroTirzepatide14$14,716
Tresiba Flextouch U-100Insulin Degludec17$8,683
Praluent PenAlirocumab12$5,983
Advair HfaFluticasone Propion/Salmeterol14$5,718
BrilintaTicagrelor19$3,993
Bumetanide67$3,324
Atorvastatin Calcium176$2,626
Gabapentin60$2,339
Duloxetine Hcl82$2,041
Losartan Potassium154$1,974

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$36$60,47245 claims
PfizerEliquis$70$38,22653 claims
Novo NordiskOzempic$162$32,96429 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Manning

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →